🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Breast Cancer Stage IV

Elacestrant in Patients With ER+ HER2- ESR1-mutated Locally Advanced or Metastatic Breast Cancer NCT07563595n/a3 sites📍 Freiburg im Breisgau📍 Paderborn📍 Ravensburg iOMEDICO AG · Tests: Elacestrant, Standard of care (Investigator Choice) A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors NCT06609187Phase 11 site📍 Beijing Sichuan Baili Pharmaceutical Co., Ltd. · Tests: GNC-077 Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer NCT06105684Phase 21 site📍 Birmingham University of Alabama at Birmingham · Tests: Capecitabine Pill A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers. NCT07593820Phase 12 sites📍 Barcelona📍 Barcelona Vall d'Hebron Institute of Oncology · Tests: p95HER2.CAR-TECH2Me Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers NCT07233928NA1 site📍 Toulouse Institut Claudius Regaud · Tests: Tumor biopsy Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer NCT05430399Phase 32 sites📍 Guangzhou📍 Hunan Sun Yat-sen University · Tests: utidelone, docetaxel Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer NCT04090567Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cediranib, Ceralasertib, Olaparib Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. NCT04305834Phase 26 sites📍 Duarte📍 Irvine📍 Long Beach City of Hope Medical Center · Tests: Abemaciclib, Questionnaire Administration Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases NCT05866432Phase 21 site📍 Vienna Medical University of Vienna · Tests: Datopotamab deruxtecan Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients NCT06962163NA1 site📍 Saint-Herblain Institut Cancerologie de l'Ouest · Tests: [68Ga]Ga-PentixaFor PET/CT Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer NCT06222879Phase 1, Phase 21 site📍 Changsha Shandong Suncadia Medicine Co., Ltd. · Tests: HRS-8080; SHR-A1811, HRS-8080; SHR-A2009, SHR-A2009; SHR-1316 A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer NCT03424005Phase 1, Phase 255 sites📍 Duarte📍 Duarte📍 Irvine Hoffmann-La Roche · Tests: Capecitabine, Atezolizumab, Ipatasertib, SGN-LIV1A, Bevacizumab Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns NCT06551220n/a26 sites📍 New Haven📍 Boston📍 Fuzhou Sun Yat-sen University · Tests: Trastuzumab Deruxtecan A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer NCT06678269Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Abemaciclib, Radiation Therapy A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors NCT07318805Phase 113 sites📍 Duarte📍 Grand Rapids📍 Long Island City Pfizer · Tests: PF-08032562, Fulvestrant, Cetuximab, Fluorouracil, Oxaliplatin Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer NCT04136782Phase 47 sites📍 Harbin📍 Changchun📍 Dalian Shengjing Hospital · Tests: Albumin-bound paclitaxel combined with carboplatin, Epirubicin combined with docetaxel Comprehensive Outcomes for After Cancer Health NCT05349227NA7 sites📍 Gainesville📍 Boston📍 Omaha Pack Health · Tests: Digital Health Coaching Program, Fitbit Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer NCT06179303Phase 23 sites📍 St Louis📍 Chapel Hill📍 Seattle University of Washington · Tests: Abemaciclib, Anastrozole, Biospecimen Collection, Computed Tomography, Diagnostic Imaging Testing Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer NCT06706557n/a1 site📍 Milan European Institute of Oncology A Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing Recurrent/Metastatic Breast Cancer NCT07678957Phase 21 site📍 Beijing Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-M07D1, DS-8201 Asciminib in HER2+ Breast Cancer Brain Metastases NCT07136428Phase 1, Phase 21 site📍 Durham Duke University · Tests: Asciminib and Trastuzumab Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer NCT05950945Phase 388 sites📍 Miami Beach📍 Tampa📍 Boston Daiichi Sankyo · Tests: Trastuzumab Deruxtecan HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan NCT06236269Phase 210 sites📍 Badalona📍 L'Hospitalet de Llobregat📍 Barcelona SOLTI Breast Cancer Research Group · Tests: Sacituzumab Govitecan A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer NCT07347600n/a32 sites📍 Xiamen📍 Lanzhou📍 Shijiazhuang Hoffmann-La Roche · Tests: Inavolisib, Palbociclib, Fulvestrant A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy NCT07071337Phase 32 sites📍 Beijing📍 Guangzhou Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Tests: SKB264, Nab-paclitaxel, Paclitaxel, Capecitabine A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1 NCT07292168Phase 1, Phase 25 sites📍 Kazan'📍 Krasnoyarsk📍 Moscow Kidney Cancer Research Bureau · Tests: humanized monoclonal anti-FGFR1 antibody OM-RCA-01 Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer NCT05524584Phase 21 site📍 Orange University of California, Irvine · Tests: Fulvestrant, Anastrozole, Abemaciclib Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer NCT07003009NA1 site📍 Istanbul Istanbul Training and Research Hospital · Tests: Malign Lymph Node Washout, Benign Lymph Node Washout HER2+ CNS Surveillance NCT07748598NA1 site📍 Liverpool The Clatterbridge Cancer Centre NHS Foundation Trust · Tests: Intervention for Arm 2: Brain MRI Surveillance Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer NCT05417308EARLY Phase 11 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Minoxidil, Minoxidil, Quality-of-Life Assessment, Questionnaire Administration
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy